Myeloproliferative Neoplasms—Patient Version
Myeloproliferative neoplasms and myelodysplastic syndromes are diseases of the blood cells. They include chronic myeloproliferative neoplasms, myelodysplastic syndromes, and myelodysplastic/myeloproliferative neoplasms.
Chronic myeloproliferative neoplasms are diseases in which the bone marrow makes too many red blood cells, platelets, or certain white blood cells.
Myelodysplastic syndromes are a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells.
Myelodysplastic/myeloproliferative neoplasms are diseases that have features of both myelodysplastic syndromes and myeloproliferative neoplasms.
Certain types of myeloproliferative neoplasms and myelodysplastic syndromes may become a type of blood cancer called acute leukemia.
PDQ Treatment Information for Patients
- Myelodysplastic Syndromes Treatment
- Chronic Myeloproliferative Neoplasms Treatment
- Myelodysplastic/ Myeloproliferative Neoplasms Treatment
- Late Effects of Treatment for Childhood Cancer (PDQ®)
- Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment–Patient Version (PDQ®)
- Drugs Approved for Myeloproliferative Neoplasms
- Clinical Trials to Treat Myelodysplastic Syndromes
- Clinical Trials to Treat Chronic Myeloproliferative Neoplasms
- Clinical Trials to Treat Myelodysplastic/Myeloproliferative Neoplasms